Healthcare - Biotechnology - NASDAQ - US
$ 12.43
-3.27 %
$ 756 M
Market Cap
-3.71
P/E
Price Target
Average
212.61%
Revenue Forecast
Estimate
202.32%
EBIT
Estimate
12.89%
Net Income
Estimate
3.92%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Pliant Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for PLRX of $38.9 , with forecasts ranging from a low of $32 to a high of $48 .
PLRX Lowest Price Target
Wall Street Target
32 USD
157.44%
PLRX Average Price Target
Wall Street Target
38.9 USD
212.61%
PLRX Highest Price Target
Wall Street Target
48 USD
286.16%
REVENUE FORECAST
Revenue Forecast Chart PLRX
EBIT FORECAST
EBIT Forecast Chart PLRX
NET INCOME FORECAST
Net Income Chart PLRX